Establishment of an In Vitro Scab Model for Investigating Different Phases of Wound Healing
暂无分享,去创建一个
S. Ehnert | J. Kolbenschlag | T. Histing | H. Rinderknecht | A. Nussler | Chaozhi Liu | Tina Histing
[1] Wei-Qiang Tan,et al. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] Guobing Chen,et al. Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury , 2020, The Journal of international medical research.
[3] F. J. Nicolás,et al. Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective , 2020, Cells.
[4] P. Greenberg,et al. MMP9 inhibition increases erythropoiesis in RPS14-deficient del(5q) MDS models through suppression of TGF-β pathways. , 2019, Blood advances.
[5] A. Nussler,et al. Impact of Four Protein Additives in Cryogels on Osteogenic Differentiation of Adipose-Derived Mesenchymal Stem Cells , 2019, Bioengineering.
[6] P. Hoff,et al. Hypoxia and mesenchymal stromal cells as key drivers of initial fracture healing in an equine in vitro fracture hematoma model , 2019, PloS one.
[7] A. Nussler,et al. Immune Cell Induced Migration of Osteoprogenitor Cells Is Mediated by TGF-β Dependent Upregulation of NOX4 and Activation of Focal Adhesion Kinase , 2018, International journal of molecular sciences.
[8] T. Quan,et al. Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts , 2017, PloS one.
[9] M. Ståhle,et al. Transition from inflammation to proliferation: a critical step during wound healing , 2016, Cellular and Molecular Life Sciences.
[10] V. Falanga,et al. Transforming growth factor beta (TGF‐β) isoforms in wound healing and fibrosis , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[11] R. Einspanier,et al. Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse , 2015, Mediators of inflammation.
[12] E. O’Toole,et al. Metalloproteinases and Wound Healing. , 2015, Advances in wound care.
[13] A. Ghahary,et al. Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing. , 2013, Advances in wound care.
[14] H. Sorg,et al. Wound Repair and Regeneration , 2012, European Surgical Research.
[15] B. Alman,et al. Fibronectin and β-Catenin Act in a Regulatory Loop in Dermal Fibroblasts to Modulate Cutaneous Healing* , 2011, The Journal of Biological Chemistry.
[16] W. Parks,et al. Metalloproteinases and their inhibitors: regulators of wound healing. , 2008, The international journal of biochemistry & cell biology.
[17] M. Storck,et al. [Chronic wounds--perspective for integrated care]. , 2007, Zentralblatt fur Chirurgie.
[18] K. Lyons,et al. CCN2 (Connective Tissue Growth Factor) is essential for extracellular matrix production and integrin signaling in chondrocytes , 2007, Journal of Cell Communication and Signaling.
[19] Finn Gottrup,et al. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. , 2004, American journal of surgery.
[20] T. Yoshizaki,et al. Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.
[21] I. Saiki,et al. Effects of Recombinant Human Tissue Inhibitor of Metalloproteinases‐2 (rh‐TIMP‐2) on Migration of Epidermal Keratinocytes In vitro and Wound Healing In vivo , 2003, The Journal of dermatology.
[22] U. Saarialho-Kere,et al. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. , 1999, Human pathology.
[23] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[24] J. Kere,et al. Patterns of matrix metalloproteinase and TIMP‐1 expression in chronic and normally healing human cutaneous wounds , 1996, The British journal of dermatology.
[25] G. Schultz,et al. Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. , 1996, Archives of otolaryngology--head & neck surgery.
[26] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Massagué,et al. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.
[28] A. Shortt,et al. TGFbeta stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. , 2008, Experimental cell research.
[29] A. Ludlow,et al. Active transforming growth factor-beta in wound repair: determination using a new assay. , 1999, The American journal of pathology.
[30] C. Heldin,et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. , 1997, Nature.
[31] M. Sporn,et al. TGF-beta: regulation of extracellular matrix. , 1992, Kidney international.
[32] M. Sporn,et al. Transforming growth factor-beta. Major role in regulation of extracellular matrix. , 1990, Annals of the New York Academy of Sciences.